Austin, Texas 6/15/2007 9:28:42 PM
News / Business

Speak with other shareholders about: (OTCBB: WBKAE), (OTCBB:ETLY), (OTCBB: CCBEF), (OTCBB: CEMI), (OTCBB: SNVH)

AUSTIN, TX: June 15, 2007 – Are you looking to speak with  other investors about your favorite stock? Stockwire.com, ranked in the top  5,000 websites in the United    States by Alexa.com/Amazon.com, has created  one of the finest chat programs available for investors. Now you can chat  real-time with like-minded individuals about your favorite stock. Visit  Stockwire.com and click the “Chat Now” button at the top.

Have you ever watched a STOCKUMENTARY? Click the following  link to view your first ever full length STOCKUMENTARY:  http://www.stockwire.com/cdrom/streaming_flash_page.htm .

----------------------------------------------------------

Talk to other TNSP shareholders by clicking the following  link: http://www.stockwire.com
   
  Tank Sports, Inc. (OTCBB: TNSP)
 
  Tank Sports announced today that it has completed the merger  of the Redcat and Tank Sports parts distribution centers. The consolidation of  the two distribution centers into one immense centralized location will provide  Tank Sports and Redcat customers with over 5,500 parts and a 600,000CF facility  stocked with parts for all current and previous model years supplied by the now  combined companies.
 
  "The China Powersports Industry is looking for a lead  supplier of not only products, but also quality parts. Tank Sports, after  consulting with many of our own customers, has decided that in an effort to  best serve the Powersports community we will take an initiative to provide  parts not only for the products we sell, but also for the over 30 brands of  other Powersports products on the market currently shipping from China,"  said Mike Turber, Recently appointed Director of Sales and Marketing.
 
  The consolidation of the two parts distribution centers is a  key factor in building the Tank brand name. "We want all dealers to see  Tank Sports as a leader in not only providing the best quality products  currently exporting from China, but also as a key supplier of parts for all  brands of Powerports products currently manufactured in China," said Tank  CEO Jiangyong Ji.
 
  By consolidating the Redcat and Tank Sports parts distribution  centers into one central location, Tank Sports has created what is perhaps the  largest single source of parts for China Powersports products in the USA.
 
  For more information about Tank Sports, Inc., visit:  http://www.tank-sports.com/
 
  ----------------------------------------------------------

Talk to other WBKAE shareholders by clicking the following  link: http://www.stockwire.com
   
  WaterBank of America (USA) Inc. (OTCBB: WBKAE)
 
  WaterBank of America, producers of ICEROCKS, ready to freeze  secured spring water ice cubes, today announced an exclusive distribution  agreement with Kruytbergh Foodservice B.V., a leading distributor of  super-premium beverages for Belgium, the Netherlands, Luxembourg and Germany.  The super-premium pre-filled ICEROCKS joins Kruytbergh's already impressive brand  portfolio, including Icelandic Glacial premium natural mineral water, and  Virgin Energy Shot.
 
  The agreement comes just one year after ICEROCKS' successful  launch in the US and Canada, leading to strong brand presence in a number of  prominent retailers. Now, with this exclusive distribution agreement, consumers  seeking the highest-quality premium ice cubes will be able to find ICEROCKS in  the Benelux and Germany.
 
  "This relationship with Kruytbergh is a significant step  in advancing ICEROCKS international growth strategy," says WaterBank of  America's President and CEO, Michel P. Pelletier. "ICEROCKS already has  received strong acceptance in the US and French markets, and we are very  excited about the brand expansion that this relationship brings, giving consumers  in the Benelux and Germany access to ICEROCKS. Kruytbergh's professionalism and  market expertise is unparalleled. Their knowledge of what consumers want  coupled with their network to deliver it to them efficiently fills us with  great confidence for success." Kruytbergh's integrated distribution  infrastructure contributed to a quick and successful market penetration of  Icelandic Glacial Natural Mineral Water. "We are partnering with ICEROCKS  at a time when the prospects for super-premium pre-filled ice cubes are  promising," says President Pieter J. Oosthoek. "The bottled water  industry is well established in the culture of Europeans and ICEROCKS is a  perfect complement." Kruytbergh will distribute ICEROCKS' full product  range, including 4 packs for on-premise accounts and 48 packs for retail  customers; with new sizes and packages coming later this year and next year.
 
  For more information about WaterBank of America, visit:  http://www.icerocks.com/
 
  ----------------------------------------------------------

Talk to other ETLY shareholders by clicking the following  link: http://www.stockwire.com
   
  ECOtality, Inc. (OTCBB:ETLY)
 
  ECOtality, Inc., a technology innovator that addresses the  global energy challenge by developing and commercializing eco-friendly  technologies, announced yesterday the acquisition of Fuel Cell Store  (www.fuelcellstore.com), a leading online retailer for the fuel cell industry.  With the acquisition, ECOtality further expands its operations into fuel cell  technologies and establishes direct relationships with top international  research institutes, universities, and leading manufacturers in the hydrogen  and fuel cell industries.
 
  "The acquisition of Fuel Cell Store further positions  ECOtality to be a leader in the industry and demonstrates our growing  confidence in the hydrogen and fuel cell sector," said Jonathan Read, CEO,  ECOtality. "With a broad product range, competitive pricing, and an  international distribution infrastructure, we believe Fuel Cell Store will be a  key player in the global development and commercialization of the hydrogen and  fuel cell markets, and an obvious vehicle for distribution of our future  products." Fuel Cell Store, based in Boulder, Colorado, distributes,  manufactures, and sells a comprehensive range of fuel cell products including  fuel cell stacks, systems, component parts and educational materials. The  company has also built its business as a leading online marketplace for fuel  cell related products and technologies, and offers consulting services,  workshops and conferences for the fuel cell industry. Currently, the company  also hosts online sites for distributors in Japan, Russia, Italy and Portugal.
 
  Working with NASA's Jet Propulsion Laboratory, GreenMountain  Engineering and Airboss Aerospace on the development of Hydratus(TM), the  acquisition of Fuel Cell Store serves as an ideal launch pad for the 5 to 10kW  Hydratus system under development by ECOtality. Hydratus is a portable  apparatus that addresses the commercialization issues facing hydrogen fuel cell  technologies by producing hydrogen on-demand -- using magnesium and water -- in  a system that emits no exhaust other than pure water.
 
  "ECOtality's financial assets and management will cement  Fuel Cell Store's position as the nexus of the hydrogen and fuel cell  industries," said Kay Quinn Larson, President, Fuel Cell Store. "This  acquisition will allow Fuel Cell Store to reinforce our position in the  industry and give us the opportunity to expand into other renewable energy  sectors."
 
  For more information about ECOtality, visit:  http://www.ecotality.com/
 
  ----------------------------------------------------------

Talk to other CCBEF shareholders by clicking the following  link: http://www.stockwire.com
   
  Clearly Canadian (OTCBB: CCBEF)
 
  Clearly Canadian announced yesterday it will be a feature  presenter at the ValueRich Small-Cap Financial Expo in Manhattan on June 21,  2007 at 9:00 a.m. EST. The event will take place at the exclusive W New York  Hotel at 541 Lexington Ave. Stated Brent Lokash, President of Clearly Canadian,  "We are pleased to present the new Clearly Canadian Brands to the  investment community. We will share our vision of positioning the Company as a  leader in the burgeoning natural and organic market sectors." CEOs and  executive teams of 30 small-cap public companies will participate in an  intimate event at the ValueRich Small-Cap Expo, which will offer one-on-one,  executive leadership training, extensive networking events and traditional  financial presentations to an audience of hundreds of investment bankers, fund  managers, institutional and accredited investors, research analysts,  accountants and attorneys. Attendance is limited to Wall Street professionals and  based on seating availability. To register for this exclusive luncheon as well  as qualify for free admission, visit: http://ivaluerich.com/expo/ny_mailer/  Onstream Media will be hosting the Web casts of the Clearly Canadian financial  presentation which will also be posted on our website at www.clearly.ca
 
  For more information about Clearly Canadian, visit:  http://www.clearly.ca/
 
  ----------------------------------------------------------

Talk to other CEMI shareholders by clicking the following  link: http://www.stockwire.com
   
  Chembio Diagnostic Systems, Inc. (OTCBB: CEMI)
 
  Chembio Diagnostic Systems, Inc. announced on 6/13/07 that it  has been issued United States Patent Number 7,192,721 for a test and  methodology to rapidly (in 20 minutes or less) detect Tuberculosis  ("TB") in multiple animal species.
 
  TB is a zoonotic disease defined as transmissible from humans  to animals and vice versa as well as within species. The occurrence of TB in  cattle is commonly referred to as bovine TB (Mycobacterium bovis, which is part  of the Mycobacterium tuberculosis complex). Bovine TB is infectious across most  mammalian species and is spread primarily through the exchange of respiratory  secretions between infected and uninfected animals. TB is a chronic disease in  which most animals show little or no symptoms of infection. Where cattle are  intended for consumption within the human food chain, slaughterhouse  surveillance for the presence of indicative organ lesions is the routine  post-mortem method employed. However, the sensitivity of post-mortem  slaughterhouse surveillance for visible lesions to detect TB is reportedly less  than 50%.
 
  The tuberculin skin test (TST) is the conventional ante-mortem  test used to screen for TB in most domestic and captive livestock species  (e.g., cattle, sheep, camels, deer, etc.) as well as those found in zoos and  other exotic wildlife. Initial results from a TST requires a minimum of 3 days  and often remains questionable until further confirmed by a repeat skin test,  the addition of more complex testing, or at animal necropsy. Moreover,  interpretation of TST is both difficult and subjective, resulting in a  significant risk that the test will yield either false positive or false  negative results.
 
  Chembio's tests are designed to offer the zoological and  agricultural markets a simple, rapid, reliable, and convenient animal-side test  for the detection of TB antibodies. Chembio's current tests incorporate single  path lateral flow technology in-licensed by Chembio. Next generation tests will  incorporate the company's Dual Path Platform (DPP(TM)) technology.
 
  Les Stutzman, VP of Marketing at Chembio, commented,  "Using our newly patented universal test method in combination with a  unique set of recombinant antigens in a simple rapid test format, Chembio is  well positioned to commercialize a line of screening products under the  company's registered STAT-PAK(R) trademark. These assays will be submitted to  USDA for full licensure and will include -- ElephantTB STAT-PAK, CamelidTB  STAT-PAK, CervidTB STAT-PAK and BovidTB STAT-PAK -- for detecting active TB in  various animal species. I am most appreciative to Javan Esfandiari, our Senior  VP of Chembio's R&D team and Konstantin Lyashchenko, PhD., Director of  Mycobacterial Immunology, for their respective roles in developing this  proprietary product line." Chembio estimates that the total commercial  global market potential for a more sensitive, rapid, and convenient veterinary  TB assay like STAT-PAK is $50 million per year; this includes applications for  slaughterhouse surveillance screening, programs that trap-test-cull livestock,  and rapid import/export screening. Chembio's initial marketing efforts will  seek to have the products used as a supplement to current TB screening methods  in zoos, exotic species conservation centers, import and export quarantine  testing facilities, and farms.
 
  Chembio is actively seeking agents or partners to assist in  developing its domestic and international distribution channels for these  products. During the interim Chembio will continue to work directly with all  interested customers for these products.
 
  For more information about Chembio Diagnostic Systems, Inc.  visit: http://www.chembio.com
 
  ----------------------------------------------------------

Talk to other SNVH shareholders by clicking the following  link: http://www.stockwire.com
   
  Synova Healthcare, Inc. (OTCBB: SNVH)
 
  Synova Healthcare, Inc. announced on 6/13/07 that it has  recently expanded the distribution of Fem-V(TM) through Longs Drugs. Longs  Drugs is one of the most recognized retail drug store chains on the West Coast.  Longs, a California based company operates more than 500 stores in California,  Hawaii, Washington, Nevada, Colorado and Oregon.
 
  Millions of women buy over-the-counter (OTC) vaginal infection  treatments, often without knowing the root cause of their vaginal infections.  Although some infections can be treated with OTC products successfully, others  cannot, and require a prescription from their health care provider. Fem-V, with  its advanced polymer technology, can assist a woman in assessing whether she  should seek professional care for her vaginal infection symptoms.
 
  Fem-V is a non-invasive, at-home test with a diagnostic strip  embedded in a pantiliner. It is highly accurate with 91% sensitivity and  provides results that are easy to interpret. Fem-V provides women with a  private and comfortable way to assess their vaginal infection symptoms.
 
  Stephen E. King, Chairman and CEO of Synova Healthcare Group,  Inc. said, "We are extremely pleased to announce Fem-V's distribution  through Longs. Longs represents another very important point of retail  distribution for Fem-V and increases access to this product for our customers.  We believe Fem-V can play an important role for the millions of women who  suffer from vaginal infections annually." The Company also believes that  many of the consumers, who will use Fem-V, represent the same target audience  for The Today(R) Sponge. Synova Healthcare acquired the exclusive worldwide  rights to the Today Sponge earlier this year, and will soon re-launch this  former #1 OTC female contraceptive to consumers nationwide. The Company intends  to aggressively co-promote and cross merchandise these two strategically aligned  healthcare products in the months ahead. Interested consumers can learn more  about Fem-V by visiting http://www.fem-v.com.
 
  ----------------------------------------------------------

As a trader, a very intelligent place to put your money, is  where the money is flowing into. These are the kind of trades that you want to  get into.

As the saying goes...follow the money!

To see the complete Movers & Shakers Blog go to:  http://www.stockwire.com .

About Stockwire:
  Stockwire is a company that is pioneering a new way to  research companies before you invest them. It's called a Stockumentary. A  Stockumentary is a documentary on a publicly traded company. Imagine a Dateline  NBC segment, but on a publicly traded company. We are the first company to ever  bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management,  product demos, video tours of office or factory, research reports, sec filings  and much more. All of this is delivered to investors in high quality video,  either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc.  (SRGI) and is an independent electronic publication committed to providing our  readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from  some of the companies from which it features. To the degrees listed herein,  this Newsletter should not be regarded as an independent publication. All  statements and expressions are the sole opinions of the editors and are subject  to change without notice. A profile, description, or other mention of a company  in the Newsletter is neither an offer nor solicitation to buy or sell any  securities mentioned.

While we believe all sources of information to be factual  and reliable, in no way do we represent or guarantee the accuracy thereof, nor  the statements made herein.

We encourage our readers to invest carefully and read the  investor information available at the web sites of the Securities and Exchange  Commission ("SEC") at www.sec.gov and/or the National Association of  Securities Dealers ("NASD") at www.nasd.com. The NASD has published  information on how to invest carefully at its web site.

Readers can review all public filings by companies at the  SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication  committed to providing our readers with factual information on selected  publicly traded companies. Stockwire.com is not a registered investment advisor  or broker-dealer. All companies are chosen on the basis of certain financial  analysis and other pertinent criteria with a view toward maximizing the upside  potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it  receives as compensation for coverage of client companies. Since the shares are  received as compensation for services as previously disclosed, and not for  investment purposes, the editors do not view the sale of the shares as  contradictory to any advice delivered in the content. This should be viewed as  a conflict of interest by shareholders or prospective shareholders of the  client companies.

Moreover, as detailed below, this publication accepts  compensation from third party consultants and/or companies which it features on  Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group  Inc. (SRGI). To the degrees enumerated herein, this newsletter and website  should not be regarded as an independent publication.

All statements and expressions are the sole opinions of the  editors and are subject to change without notice. A profile, description, or  other mention of a company on Stockwire.com is neither an offer nor  solicitation to buy or sell any securities mentioned. While we believe all  sources of information to be factual and reliable, in no way do we represent or  guarantee the accuracy thereof, nor the statements made herein.

The editor, members of the editor's family, and/or entities  with which the editor is affiliated aside from Stockwire Research Group Inc.  (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise  trade stock for their own benefit in the companies who appear in the  publication unless specifically disclosed in the newsletter.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE  DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES  IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS  PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE  COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE  EDITORS OF STOCKWIRE.COM.

We often accept restricted shares of company stock; by SEC  regulations, restricted shares cannot be sold into the market for a period of  at least one year from the time that the shares are issued. In such cases, we  detail in the Disclaimer the specific term of any restrictions. We also receive  compensation in the form of stock options, in which case we receive the right  to buy shares of the stock of the company at issue, at a specified time and a  specified price. In such circumstances, we specify on our Disclaimer the terms  of the options received. On occasion, we also accept free-trading shares in a  company that we cover. However, by policy we generally do not buy or sell any  shares of a company's stock within three trading days after any such company's  profile, commentary, or other company-specific information is disseminated on  Stockwire.com Web site. In cases where we do trade within the three day window,  our volume will never represent more than 5% of the daily volume, thereby  minimizing any effect we could have on the potential price movement.

While our policies as detailed above are designed to  minimize any impact upon our members of a conflict of interest between our  company and our members, each member should be fully aware that such potential  and actual conflicts of interest may well exist due to the compensation  structure detailed herein. For this reason, and because the information  contained on Stockwire.com is updated on a regular basis as circumstances  change, each member is strongly encouraged to periodically review the Profile  Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .

Stockwire Research Group, Inc. .
  512.358.8440 .
  info@stockwire.com .